Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults
Cardiovascular Pathology, 07/27/2012
Parson SJ et al. – This is the first study to incorporate lipofuscin in predicting future heart function. Authors found that more lipofuscin correlates with better EFs at 1 year, suggesting that lipofuscin is a marker for improved cardiac compensation. This information can help clinicians devise treatment plans for individuals in this age group.